The use of Huperzia species for the treatment of Alzheimer’s disease

Author:

Kim Thu Dang1,Vui Dao Thi2,Ngoc Huyen Nguyen Thi1,Duyen Duong Ky1,Thanh Tung Bui3

Affiliation:

1. VNU School of Medicine and Pharmacy Vietnam National University, Hanoi, Viet Nam

2. Ha Noi University of Pharmacy, Ha Noi, Vietnam

3. VNU School of Medicine and Pharmacy, Vietnam National University, Hanoi, 144 Xuan Thuy, Cau Giay Ha Noi, Viet Nam

Abstract

AbstractAlzheimer’s disease (AD), which relates to nervous degeneration, is the most popular form of memory loss. The pathogenesis of AD is not fully understood, and there are no therapies for this disorder. Some drugs have been used in clinical applications for preventing and treating AD, but they have significant adverse reactions. Therefore, there is a need to develop treatment for AD. Traditional medicine has used many medicinal plants to alleviate the symptoms of AD. Medicinal plants may reduce neurodegenerative disorders with fewer side effects than chemical drugs, and they are promising drug candidates for AD therapy. This review is the summary of the pathogenesis and treatments of AD and includes information about the chemistry and bioactivities of some medicinal plants from theHuperziaspecies, such asHuperzia saururus,Huperzia selago,Huperzia phlegmaria,Huperzia fargesii,Huperzia serrata,Huperzia reflexaandHuperzia quadrifariata, that are used for the treatment of AD. We searched literature, including Medline, Embase, Google Scholar and PubMed database, and did a bibliographic review of relevant articles. Key words includedHuperziaspecies, huperzine, huperin, Huperzia and Alzheimer’s disease. We found that the main bioactive compounds of theHuperziaspecies are alkaloids, which have shown significant effects on preventing the development of AD. They are new promising compounds against AD due to their antioxidant, anti-inflammatory and acetylcholinesterase inhibitory activities in the neural system. Our conclusion from this review is thatthe Huperziaspecies are potential source containing various pharmaceutical compounds for the treatment of AD.

Publisher

Walter de Gruyter GmbH

Subject

Drug Discovery,Pharmacology,General Medicine,Physiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3